Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Up 27.2% in November

Silo Pharma, Inc. (NASDAQ:SILOGet Free Report) was the recipient of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 129,600 shares, an increase of 27.2% from the October 31st total of 101,900 shares. Currently, 3.0% of the shares of the company are short sold. Based on an average daily trading volume, of 178,200 shares, the days-to-cover ratio is currently 0.7 days.

Silo Pharma Price Performance

NASDAQ SILO opened at $1.00 on Monday. Silo Pharma has a 52-week low of $0.77 and a 52-week high of $4.50. The business’s 50-day moving average price is $1.08 and its 200 day moving average price is $1.33.

About Silo Pharma

(Get Free Report)

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.

See Also

Receive News & Ratings for Silo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.